The Leukemia and Bone Marrow Failure Program offers a comprehensive approach to acute and chronic leukemia, myeloproliferative syndromes (such as polycythemia vera and myelofibrosis), myelodysplastic syndromes and aplastic anemia.

Special Programs:

Myeloproliferative Disease Center provides comprehensive care and innovative research for patients with polycythemia, thrombocytosis, myelocibrosis and leukemia.

Innovative clinical trials involving newly developed drugs, biological therapies, and antibodies